SCHEMBL5380646

SCHEMBL5380646

O=C(NC1CC2CCN(CC2)C1)n1cc(-c2ccc(F)cc2)cn1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PAX8 Q06710 1/20 0.40
CHRNA7 P36544 8/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
TRPA1 O75762 1/20 0.36
USP30 Q70CQ3 1/20 0.35
CHRNB2 P17787 3/20 0.34
CHRNB4 P30926 3/20 0.34
CHRNA3 P32297 3/20 0.34
CHRNA4 P43681 3/20 0.34
GRIN2B Q13224 3/20 0.34
CHRM3 P20309 1/20 0.34
NTMT1 Q9BV86 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382095 0.94 CHRNA7 (0.44) PAX8CHRNA7DRD2DRD4TRPA1
SCHEMBL5382100 0.94 CHRNA7 (0.44) PAX8CHRNA7DRD2DRD4TRPA1
SCHEMBL5380124 0.89 CHRNA7 (0.37) CHRNA7USP30GRIN2BNPC1RAB9A
SCHEMBL5376285 0.89 CHRNA7 (0.50) CHRNA7DRD2DRD4USP30NPC1
SCHEMBL5376681 0.89 CHRNA7 (0.39) CHRNA7DRD2DRD4USP30
SCHEMBL5375158 0.87 DRD2 (0.40) PAX8CHRNA7DRD2DRD4CHRNB2
SCHEMBL5376683 0.86 CCNA2 (0.39) PAX8CHRNA7USP30CHRNB2CHRNA4
SCHEMBL5387562 0.84 GRIN2B (0.37) PAX8CHRNA7USP30GRIN2B
SCHEMBL5368281 0.83 CHRNA7 (0.58) CHRNA7DRD2DRD4USP30ALDH1A1
SCHEMBL5368276 0.83 CHRNA7 (0.58) CHRNA7DRD2DRD4USP30ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176198-B2 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease PFIZER INC. (US) 2007-02-13 US claimed
US-20060116395-A1 1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of disease PFIZER INC 2006-06-01 US claimed
US-20040087616-A1 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease PIOTROWSKI DAVID W (US) 2004-05-06 US claimed
US-7176198-B2 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease PFIZER INC. (US) 2007-02-13 US disclosed
US-20060116395-A1 1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of disease PFIZER INC 2006-06-01 US disclosed
EP-1542999-A1 1H-PYRAZOLE AND 1H-PYRROLE-AZABICYCLIC COMPOUNDS WITH ALFA-7 NACHR ACTIVITY Pharmacia & Upjohn Company LLC (US) 2005-06-22 EP disclosed
US-20040087616-A1 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease PIOTROWSKI DAVID W (US) 2004-05-06 US disclosed
WO-2004013137-A1 1H-PYRAZOLE AND 1H-PYRROLE-AZABICYCLIC COMPOUNDS WITH ALFA-7 NACHR ACTIVITY PHARMACIA & UPJOHN COMPANY LLC (US) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116395-A1 1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of disease CYP7B1, P2RX7, CYP3A7 PAX8 1226/4885CHRNA7 8/4885DRD2 4113/4885
US-20040087616-A1 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease CYP1B1, TPMT, CYP7B1 PAX8 1771/4885CHRNA7 2586/4885DRD2 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.